Completed OBSERVATIONAL NCT02295384

Use of Concomitant Medications in HIV-1 Infected Patients in a Large Community Practice in Sydney, Australia

Sponsor: Gilead Sciences

Conditions HIV

Updated 6 times since 2017 Last updated: Sep 8, 2016 Started: Nov 30, 2014 Primary completion: Dec 31, 2015 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates HIV and is currently completed. Gilead Sciences leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gilead Sciences
Holdsworth House Medical Practice

Data source: Holdsworth House Medical Practice

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Darlinghurst, Australia